Longitudinal assessments in discordant twins with SMA

[1]  A. Hoischen,et al.  Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis. , 2017, American journal of human genetics.

[2]  A. Büschges,et al.  The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype. , 2016, American journal of human genetics.

[3]  R. Finkel,et al.  Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials , 2015, Neuromuscular Disorders.

[4]  M. Rich,et al.  Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse , 2015, PloS one.

[5]  Wang Hong,et al.  Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy , 2013, Journal of Human Genetics.

[6]  B. Wirth,et al.  How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches. , 2013, Current opinion in genetics & development.

[7]  R. Finkel.  Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I , 2013, Neuromuscular Disorders.

[8]  E. Bertini,et al.  Childhood spinal muscular atrophy: controversies and challenges , 2012, The Lancet Neurology.

[9]  C. Hernández-Chico,et al.  Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings , 2011, Neuromuscular Disorders.

[10]  M. Schroth,et al.  Compound muscle action potential and motor function in children with spinal muscular atrophy , 2010, Muscle & nerve.

[11]  W. Chung,et al.  Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females. , 2010, Archives of neurology.

[12]  R. Finkel,et al.  The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability , 2010, Neuromuscular Disorders.

[13]  Mitchell R Lunn,et al.  Spinal muscular atrophy , 2008, The Lancet.

[14]  B. Wirth,et al.  Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy , 2008, Science.

[15]  Mark B Bromberg,et al.  Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function , 2005, Annals of neurology.

[16]  E. Bertini,et al.  SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR , 2010, European Journal of Human Genetics.